← Leaderboards
Farhad Vesuna
Natsar Pharmaceuticals, Inc.
$817,406
Attributed
$1,634,811
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$1,634,811 · 1
By mechanism
R44$1,634,811 · 1
Top collaborators
- Dominic A Ventura1 shared
Most similar at Natsar Pharmaceuticals, Inc.
Same institution · by research overlap
- Dominic A Ventura$817,406
Others in their field
Other Rising Stars on “Adjuvant Chemotherapy”
- Kathryn Marie Jones · Baylor College Of Medicine$3,103,804
- Amy Fowler · University Of Wisconsin-Madison$3,008,001
- Alice Chia- Chi Wei · Sloan-Kettering Inst Can Research$2,617,533
- Nadine Norton · Mayo Clinic Jacksonville$2,431,858
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$2,101,095
- Nduka Mgbechinyere Amankulor · University Of Pennsylvania$2,082,285
Research focus
Adjuvant ChemotherapyAffectAfrican American WomenAnalytical MethodAnti-CancerBindingBiogenesisBiological AvailabilityBiological MarkersBreast Cancer MetastasisBreast Cancer ModelBreast Cancer PatientBreast Cancer TreatmentBuffersCancer CellCancer ModelCancer TherapyCancer TypeCanis FamiliarisCardiovascular PhysiologyCaspaseCell Death InductionCellsAcids